Centre for Human Drug Research

Leiden 75 trials 25 recruiting

75 Registered trials

25 Currently recruiting

Organisation

Centre for Human Drug Research

Location

Leiden, Netherlands

Identifier

ORG-100008266

Address

Zernikedreef 8, 2333 CL, Netherlands

Departments

-
#1003: Internal Medicine
9001: Internal Medicine
Center for Human Drug Research
CHDR
Department of Neurology
Dermatology
Experimental Medicine
Immunology
Infectious Diseases
Internal Medicine
n.a.
NA
Neurology
Neurology dep.
Pain
Psychiatry
Psychology
Translational Dermatology

Clinical trials at this site (75)

Search interface

A study to find how well LY3884961 works and how safe it is in participants with Parkinson’s disease Not authorised

2024-519587-40-00 Parkinson’s Disease with at Least One GBA1 Mutation 7
A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease Pending

2024-517310-15-00 Parkinson's Disease 3
Study on the effect of 6qc-ICG on the skin of healthy volunteers and in patients with breast cancer during surgeries. Pending

2025-523166-24-00 Breast cancer 7
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a… Recruiting

2024-520196-27-00 Rheumatoid Arthritis 3 2025-10-01
SAR447971 first-in-human study Recruiting

2026-525333-22-00 Hidradenitis 1 2026-05-22
Effect of NBI-921355 on corticospinal excitability in healthy participants Recruiting

2025-524134-26-00 Epilepsy 3 2026-05-08
A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune medi… Recruiting

2026-525575-22-00 Psoriasis 1 2026-05-07
CSX-1004 Effects on Fentanyl-Induced Respiratory Depression Recruiting

2025-524133-33-00 Opioid use disorder 4 2026-03-27
A trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis Recruiting

2025-522922-11-00 Progressive multiple sclerosis (MS) 4 2026-03-03
A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic periph… Recruiting

2025-524258-32-00 Diabetic Peripheral Neuropathy (DPN) 1 2026-03-02
A Phase 1 Study of Fentanyl Vaccine Recruiting

2025-524277-16-00 Opioid induced respiratory depression 7 2026-02-26
Single and multiple ascending dose of ZP9830 in healthy participants Recruiting

2023-509929-51-00 Autoimmune diseases 1 2026-02-10
A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers. Recruiting

2025-523328-31-00 Inflammatory diseases 1 2026-02-06
A Study to Investigate ARV-027 in Healthy Male Participants and Participants with Spinal and Bulbar Muscular Atrophy Recruiting

2025-523469-79-00 Spinal and Bulbar Muscular Atrophy 1 2026-01-16
First-in-Human Study of ALN-SNCA in Adult Participants with Early Parkinson’s Disease (PD) Recruiting

2025-521431-37-00 Parkinson's disease 1 2025-11-20
Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS Recruiting

2025-523872-22-00 Parkinsons's Disease and amyotrophic lateral sclerosis 1 2025-11-18
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults Recruiting

2025-522930-29-00 Incomplete Response - Major Depressive Disorder (IR-MDD 3 2025-11-17
Research into the safety of a new agent (AX-5006) in people with and without Parkinson's disease. Recruiting

2025-523254-14-00 Parkinson's disease 1 2025-10-27
A Study to Evaluate the Effect of TRIV-509 on Skin Barrier Function in Patients with Atopic Dermatitis. Recruiting

2025-522635-34-00 Atopic Dermatitis 3 2025-10-09
CO2 challenge study of NTX-1955 in healthy participants Recruiting

2025-522281-68-00 Generalized Anxiety Disorder (GAD) 3 2025-08-08
To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in heal… Recruiting

2025-521357-17-00 Parkinson's disease 1 2025-06-13
Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1 Recruiting

2023-509748-89-00 Facioscapulohumeral muscular dystrophy (FSHD) 7 2025-02-19
A placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009 Recruiting

2024-517547-31-00 Rheumatoid Arthritis 1 2025-01-31
A first-in-human study of the safety of an immunosuppressive antibody (IMP761) in healthy volunteers. Recruiting

2024-510761-42-00 autoimmunity 1 2024-07-17